Pfizer Asks FDA to Authorize COVID-19 Jab for Kids Under 5

A child's dose of Pfizer's COVID-19 vaccine is seen in Washington on Nov. 3, 2021. Carolyn Kaster/AP Photo

Pfizer and its German pharmaceutical partner BioNTech announced they are submitting a request to the U.S. Food and Drug Administration (FDA) to authorize extra-low doses of their COVID-19 vaccine for children 6 months through 4 years of age.

The FDA had urged Pfizer-BioNTech to apply for the Emergency Use Authorization (EUA) earlier than the companies had planned.